H.R. 4299 · 113th Congress
Improving Regulatory Transparency for New Medical Therapies Act
- Stage
- Reported from committee
- Sponsor
- Joseph Pitts
- Introduced
- 2014-03-26
- Latest action
- 2014-09-19 · Reported (Amended) by the Committee on Judiciary. H. Rept. 113-565, Part II.
Action history
- 2014-09-19Reported (Amended) by the Committee on Judiciary. H. Rept. 113-565, Part II.
- 2014-09-19Placed on the Union Calendar, Calendar No. 451.
- 2014-09-10Committee Consideration and Mark-up Session Held.
- 2014-09-10Ordered to be Reported (Amended) by Voice Vote.
- 2014-09-09Subcommittee on Crime, Terrorism, Homeland Security, and Investigations Discharged.
- 2014-07-29Reported by the Committee on Energy and Commerce. H. Rept. 113-565, Part I.
- 2014-07-29House Committee on the Judiciary Granted an extension for further consideration ending not later than Sept. 19, 2014.
- 2014-06-10Committee Consideration and Mark-up Session Held.
- 2014-06-10Ordered to be Reported by Voice Vote.
- 2014-06-09Committee Consideration and Mark-up Session Held.
- 2014-05-28Subcommittee Consideration and Mark-up Session Held.
- 2014-05-28Forwarded by Subcommittee to Full Committee by Voice Vote .
- 2014-04-16Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- 2014-03-28Referred to the Subcommittee on Health.
- 2014-03-26Introduced in House
- 2014-03-26Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2014-03-26Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.